Basal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Basal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC) Patients [Phase 2]
A Phase 2 trial is evaluating the efficacy and safety of cemiplimab as a first-line treatment for patients with advanced basal cell carcinom…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC) [Phase 2]
A Phase 2 clinical trial update evaluating L19IL2, L19TNF, or L19IL2/TNF for locally advanced basal cell carcinoma, sponsored by Philogen S.…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: L19IL2/TNF in Patients With Basal Cell Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating L19IL2/TNF for basal cell carcinoma is currently not recruiting.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Flash Radiotherapy for Skin Cancer [Phase 2]
Phase 2 trial of flash radiotherapy for skin cancers is not yet recruiting.
-
EMA approval · 2026-02-20EMA Authorised: Ameluz (5-aminolevulinic acid hydrochloride) — Biofrontera Bioscience GmbH
EMA authorized Ameluz (5-aminolevulinic acid hydrochloride) by Biofrontera Bioscience for actinic keratosis and basal cell carcinoma, markin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma [EARLY_Phase 1]
An early-phase 1 trial evaluating intratumoral injections of two natural killer cell products for skin cancers (basal cell carcinoma and squ…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma [Phase 2]
Phase 2 trial comparing neoadjuvant nivolumab plus relatlimab (Opdualag) versus nivolumab alone in resectable high-risk basal cell carcinoma…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Pilot Study of Line-Field Confocal Optical Coherence Tomography for Detection of Mohs Micrographic Surgery Margins of Basal Cell Carcinomas [NA]
A pilot study evaluating line-field confocal optical coherence tomography for detecting Mohs micrographic surgery margins in basal cell carc…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: High Intensity Focused Ultrasound vs. Cryotherapy in the Treatment of Basal Cell Carcinomas and Bowen's Disease in Adults [NA]
The update describes a trial comparing high-intensity focused ultrasound with cryotherapy for superficial and nodular basal cell carcinomas …
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Photodynamic Therapy Associated With Sonodynamic Therapy for the Treatment of Nodular Basal Cell Carcinoma [Phase 3]
Phase 3 clinical trial evaluating the combination of Photodynamic Therapy and Sonodynamic Therapy for nodular basal cell carcinoma of the sk…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas [Phase 1]
A Phase 1 study evaluating blue-light photodynamic therapy in combination with sonidegib for multiple basal cell carcinomas is currently rec…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Clinical Trial to Evaluate BO-112 in Patients With Basal Cell Carcinoma (BCC) [Phase 2]
Phase 2 clinical trial evaluating BO-112 in basal cell carcinoma is currently active but not recruiting.
-
EMA approval · 2026-01-22EMA Authorised: Erivedge (vismodegib) — Roche Registration GmbH
The European Medicines Agency authorised Erivedge (vismodegib) by Roche Registration GmbH for basal cell carcinoma.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Basal Cell Carcinoma Chemoprevention Trial [Phase 3]
A Phase 3 clinical trial evaluating basal cell carcinoma chemoprevention is currently not recruiting.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Artificial Intelligence Enhanced Optical Coherence Tomography (AI-OCT) Imaging for Pre-surgical Margin Detection of Basal Cell Carcinoma
A clinical trial studying AI-enhanced Optical Coherence Tomography for pre-surgical margin detection in basal cell carcinoma is currently no…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma [Phase 1]
Phase 1 clinical trial update of intralesional cemiplimab in adults with cutaneous squamous cell carcinoma or basal cell carcinoma has compl…
-
EMA approval · 2026-01-20EMA Authorised: Odomzo (sonidegib diphosphate) — Sun Pharmaceutical Industries Europe B.V.
The European Medicines Agency has authorised Odomzo (sonidegib diphosphate) for basal cell carcinoma, with Sun Pharmaceutical Industries Eur…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors [Phase 1]
A Phase 1 trial evaluating in situ immunomodulation using CDX-301, CDX-1140, and Poly-ICLC with radiation therapy in patients with unresecta…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Treatment of Basal Cell Carcinoma (BCC) of the Skin, of the Morpheiform, Infiltrative, and Noduloulcerative Types in Inoperable Patients and Not Suitable for Radiotherapy Using Formulated Methylene Blue [Phase 3]
Phase 3 study evaluating a formulated methylene blue for inoperable, radiotherapy-unfit advanced basal cell carcinoma (including morpheaform…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Electronic Skin Surface Brachytherapy for Cutaneous Basal Cell and Squamous Cell Carcinoma [NA]
The trial update indicates that the electronic skin surface brachytherapy study for cutaneous basal cell carcinoma and cutaneous squamous ce…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas [Phase 2]
A Phase 2 clinical trial update describes a program for in-home cancer treatment with remote expert support, currently recruiting for patien…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers
A clinical trial update announcing a liquid biomarker study in melanoma and non-melanoma skin cancers that is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinoma [Phase 2]
Phase 2 study evaluating neoadjuvant sonidegib followed by surgery or imiquimod in basal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer [Phase 2]
A Phase 2 trial evaluating Vidutolimod in combination with cemiplimab for adults with advanced or metastatic cancers was terminated, with re…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer [Phase 1]
Phase 1 clinical trial evaluating MQ710 with and without pembrolizumab in solid tumors; the study is currently recruiting.